Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Jaromir
Jaromir Cacala, Ostrava CZ
| Patent application number | Description | Published |
|---|---|---|
| 20100014305 | Device For Automatic Switching Of A Touring Shutter By Extreme Travel Of The Height Adjustment Of A Headlight - A device for automatic switching of the touring diaphragm by an extreme travel of the height controls of the headlight is provided with a mechanism for changing the spatial distribution of the light, consisting of a projector ( | 01-21-2010 |
Jaromir Dzialo, Krakow PL
| Patent application number | Description | Published |
|---|---|---|
| 20100228693 | METHOD AND SYSTEM FOR GENERATING A DOCUMENT REPRESENTATION - A method, system and computer program product for generating a document representation are disclosed. The system includes a server and a client computer, and the method involves: receiving into memory a resource containing at least one sentence of text; producing a tree comprising tree elements indicating parts-of-speech and grammatical relations between the tree elements; producing semantic structures each having three tree elements to represent a simple clause (subject-predicate-object); and storing a semantic network of semantic structures and connections therebetween. The semantic network may be created from a user provided root concept. Output representations include concept maps, facts listings, text summaries, tag clouds, indices; and an annotated text. The system interactively modifies semantic networks in response to user feedback, and produces personal semantic networks and document use histories. | 09-09-2010 |
Jaromir Kur, Ingolstadt DE
| Patent application number | Description | Published |
|---|---|---|
| 20090218783 | Wheel suspension for motor vehicles - The invention relates to a suspension for the wheels of an axle of a motor vehicle, especially for the steered front wheels. Said wheel suspension comprises wheel carriers that rotatably bear the wheels and are arranged so as to create straight-line steering via several individual links which are pivotally connected to the motor vehicle body and one respective track rod. Resilient means which directly or indirectly impress a certain prestress that acts around the spread axle of the wheels and in the opposite direction are provided in the wheel suspension in order to improve steering return and steering precision. | 09-03-2009 |
Jaromir Palata, Friedrichshafen DE
| Patent application number | Description | Published |
|---|---|---|
| 20080204051 | CAPACITIVE SENSOR - A capacitive sensor with at least one reference impedance and at least one measuring condenser ( | 08-28-2008 |
| 20100313653 | Admittance meter for monitoring a medium - An admittance meter having an electrical alternating signal source, a diode ring operated as a synchronous rectifier with at least four diodes connected in series and in the same direction in succession, a measuring sensor, and an evaluation unit. The diode ring is subjected to an alternating signal via first second feed points, which are each connected via two series-connected diodes. The measuring sensor is connected to the first feed point, and the evaluation unit is connected to a first or a second measurement point of the diode ring. The first and second measurement points are each connected via one diode to the first and second feed points, respectively. | 12-16-2010 |
Jaromir Pastorek, Stupava SK
| Patent application number | Description | Published |
|---|---|---|
| 20090176240 | MN/CA IX and Cancer Prognosis - Herein disclosed are methods that are prognostic for neoplastic/preneoplastic disease in a subject vertebrate, wherein said disease is associated with a tissue that normally expresses MN, but which MN expression is lost or diminished upon carcinogenesis. Exemplary of the types of preneoplastic/neoplastic diseases subject to the prognostic methods of this invention are those of gastric mucosa, gallbladder, biliary ducts, and ductal cells of duodenal glands. An exemplary prognostic method comprises comparing the level of MN gene expression product in a tissue sample from the affected subject, with the average MN gene expression product level found in analogous preneoplastic/neoplastic tissue samples; an above average MN gene expression product level indicates poorer prognosis for the subject. MN gene expression products useful in the prognostic methods include MN protein, MN polypeptide, and/or MN nucleic acids. | 07-09-2009 |
| 20100056611 | MN/CA9 Splice Variants - Herein disclosed is an alternatively-spliced [AS] variant of MN/CA9 mRNA and its related protein—AS MN/CA IX. Unlike the tumor-associated, full-length [FL] MN/CA9 mRNA and FL MN/CA IX, which in most tissues signify oncogenesis and/or hypoxia, the AS MN/CA9 mRNA is constitutively-expressed under normoxia and is not stimulated by hypoxia, and the AS MN/CA IX is not confined to the cell membrane. Provided herein are diagnostic/prognostic methods for preneoplastic/neoplastic disease to differentiate between AS and FL MN/CA9 expression, and probes, primers, and antibodies useful in such methods. Also disclosed are methods to treat pre-neoplastic/neoplastic disease involving the MN gene and protein, which methods are based on the ability of AS MN protein (AS MN/CA IX) to interfere with the catalytic activity of FL MN protein (FL MN/CA IX); such methods may also use AS MN protein fragments that have that interference capability. Such methods may comprise increasing the levels of AS MN/CA IX relative to the levels of FL MN/CA IX. Exemplary therapeutic methods may comprise the administration of agents, such as, AS MN/CA IX itself, a vector expressing AS MN/CA9 mRNA, an antisense oligonucleotide that blocks expression of FL MN/CA IX but not that of AS MN/CA IX, a vector expressing such an antisense oligonucleotide, a FL MN/CA9 isoform-specific siRNA, or a vector expressing such FL MN/CA9 isoform-specific siRNA. Further disclosed are methods to identify agents capable of modulating levels of AS MN/CA IX. | 03-04-2010 |
| 20100267040 | MN/CA IX and Cancer Prognosis - Herein disclosed are methods that are prognostic for neoplastic/preneoplastic disease in a subject vertebrate, wherein said disease is associated with a tissue that normally expresses MN, but which MN expression is lost or diminished upon carcinogenesis. Exemplary of the types of preneoplastic/neoplastic diseases subject to the prognostic methods of this invention are those of gastric mucosa, gallbladder, biliary ducts, and ductal cells of duodenal glands. An exemplary prognostic method comprises comparing the level of MN gene expression product in a tissue sample from the affected subject, with the average MN gene expression product level found in analogous preneoplastic/neoplastic tissue samples; an above average MN gene expression product level indicates poorer prognosis for the subject. MN gene expression products useful in the prognostic methods include MN protein, MN polypeptide, and/or MN nucleic acids. | 10-21-2010 |
Jaromir Plesek, Praha CZ
| Patent application number | Description | Published |
|---|---|---|
| 20090012044 | Novel Hiv Protease Inhibitors - The present invention provides novel HIV protease inhibitors containing substituted borane, carborane or metallacarborane clusters with 6 to 12 boron atoms in each cluster. The charge of each borane, carborane or metallacarborane cluster is 0, −1 or −2. The number of borane, carborane or metallacarborane clusters in the inhibitor molecule is 1 to 9, and the carborane clusters in metallacarborane inhibitors are coordinated to transition metal atom, selected from the group containing cobalt, iron, nickel and ruthenium. In the cluster, heteroatoms can be present, such as nitrogen, phosphorus, silicon, germanium, tin and sulphur. The present invention covers pharmaceutical compositions containing these inhibitors and their use, both in vitro and in vivo. They are characterized by high effectiveness and stability. | 01-08-2009 |
Jaromir Podzemny, Brno CZ
| Patent application number | Description | Published |
|---|---|---|
| 20120001645 | COMBINED ELECTRICAL VARIABLE DETECTION DEVICE - A combined electrical variable detection device comprises a plurality of single-phase current measuring modules ( | 01-05-2012 |
Jaromir Vlach, Annandale, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100291034 | COMBINATIONS OF HCV PROTEASE INHIBITOR(S) AND CYP3A4 INHIBITOR(S), AND METHODS OF TREATMENT RELATED THERETO - Disclosed are medicaments, pharmaceutical compositions, pharmaceutical kits, and methods based on combinations comprising, separately or together: (a) a CYP3A4 inhibitor; and (b) a HCV protease inhibitor; for concurrent or consecutive administration in treating a human subject infected with HCV. | 11-18-2010 |